ACTRAPID Side Effects

7020151-5 | Hypoglycaemia, Intentional Overdose, Suicide Attempt
on Sep 21, 2010 Male patient from SPAIN , 61 years of age, was diagnosed with type 1 diabetes mellitus, hyperlipidaemia and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, intentional overdose, suicide attempt. Actrapid dosage: 40 U, Qd. During the same period patient was treated with LEVEMIR (39 U, Qd) (View Levemir Review and Levemir Label ), ATORVASTATIN CALCIUM (10 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6966726-0 | Atrial Septal Defect, Congenital Diaphragmatic Hernia
Patient was taking Actrapid (View Usage). Patient had the following side effects: atrial septal defect, congenital diaphragmatic hernia on Aug 19, 2010 from FRANCE Additional patient health information: Female patient , weighting 4.43 lb, . Actrapid dosage: . During the same period patient was treated with INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ).

6957566-7 | Cardio-respiratory Arrest, Hypokalaemia
Adverse event was reported on Aug 23, 2010 by a Male patient taking Actrapid (View Usage) (Dosage: ) was diagnosed with diabetic ketoacidosis and. Location: SPAIN , 52 years of age, After Actrapid was administered, patient had the following side effects: cardio-respiratory arrest, hypokalaemia. During the same period patient was treated with POTASSIUM (Unk) (View Potassium Review and Potassium Label ), SODIUM BICARBONATE (Unk) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), PANTOPRAZOLE (40 Mg) (View Pantoprazole Review and Pantoprazole Label ), URBASON /00049601/ (80 Mg, Qd) (View Urbason /00049601/ Review and Urbason /00049601/ Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6955404-X | Atrial Septal Defect, Congenital Diaphragmatic Hernia, Respiratory Tract Malformation
on Aug 19, 2010 Female patient from FRANCE , weighting 4.43 lb, was diagnosed with type 1 diabetes mellitus, epilepsy (What is epilepsy?) and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, congenital diaphragmatic hernia, respiratory tract malformation. Actrapid dosage: . During the same period patient was treated with INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ), DEPAKENE (750 Mg, Unk) (View Depakene Review and Depakene Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG (Unk, Unk) (View Humalog Review and Humalog Label ).


6955034-X | Atrial Septal Defect, Congenital Diaphragmatic Hernia
on Aug 19, 2010 Female patient from FRANCE , weighting 4.43 lb, was treated with Actrapid (View Usage). Patient had the following side effects: atrial septal defect, congenital diaphragmatic hernia. Actrapid dosage: . During the same period patient was treated with INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ).

6862271-1 | Brain Injury, Fall, Hypoglycaemic Seizure
Patient was taking Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: brain injury, fall (What is fall?), hypoglycaemic seizure on Jul 08, 2010 from NEW ZEALAND Additional patient health information: Male patient , 55 years of age, was diagnosed with type 1 diabetes mellitus and. Actrapid dosage: . During the same period patient was treated with PROTAPHANE (View Protaphane Review and Protaphane Label ).

6856257-0 | Accident, Alcohol Use, Brain Injury, Fall, Hypoglycaemic Seizure, Treatment Noncompliance
Adverse event was reported on Jul 08, 2010 by a Male patient taking Actrapid (View Usage) (Dosage: ) was diagnosed with type 1 diabetes mellitus and. Location: NEW ZEALAND , 55 years of age, Patient experienced the following unwanted or unexpected effects: accident, alcohol use, brain injury, fall (What is fall?), hypoglycaemic seizure, treatment noncompliance. During the same period patient was treated with PROTAPHANE (View Protaphane Review and Protaphane Label ).

6812180-9 | Depression, Hypoglycaemia, Hypokalaemia
on Jun 22, 2010 Female patient from GERMANY , 52 years of age, weighting 286.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient had the following side effects: depression (What is depression?), hypoglycaemia, hypokalaemia. Actrapid dosage: Unk. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ), METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), ZOP (Unk) (View Zop Review and Zop Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), LOCOL (Unk) (View Locol Review and Locol Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6737561-3 | Fall, Hypoglycaemic Seizure
on May 14, 2010 Male patient from NEW ZEALAND , 55 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: fall (What is fall?), hypoglycaemic seizure. Actrapid dosage: . During the same period patient was treated with PROTAPHANE (View Protaphane Review and Protaphane Label ).

6690965-X | Hyperthermia, Infusion Site Phlebitis
Patient was taking Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthermia, infusion site phlebitis on Apr 14, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with type 2 diabetes mellitus and. Actrapid dosage: Uk/iv. During the same period patient was treated with LOXEN (6 Pharmaceutical Doses Pr Hour) (View Loxen Review and Loxen Label ), COAPROVEL (Unk) (View Coaprovel Review and Coaprovel Label ), PREVISCAN /00261401/ (20 Mg, Unk) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LERCAN (View Lercan Review and Lercan Label ), NORSET (View Norset Review and Norset Label ), IMOVANE (7.5 Mg, Unk) (View Imovane Review and Imovane Label ), LEVOTHYROX (125 Ug, Unk) (View Levothyrox Review and Levothyrox Label ), MOPRAL /00661201/ (20 Mg, Unk) (View Mopral /00661201/ Review and Mopral /00661201/ Label ). Patient was hospitalized.

6689088-5 | Stevens-johnson Syndrome
Adverse event was reported on Apr 12, 2010 by a Female patient taking Actrapid (View Usage) (Dosage: Uk/sc) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 47 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with HUMALOG (Unk) (View Humalog Review and Humalog Label ), PROPOFOL (View Propofol Review and Propofol Label ), AUGMENTIN '125' (6 G, Qd) (View Augmentin '125' Review and Augmentin '125' Label ), MOPRAL /00661201/ (40 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), CANCIDAS (50 Mg, Qd) (View Cancidas Review and Cancidas Label ), SUFENTANIL CITRATE (Unk) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), METFORMIN HCL (300 Mg, Qd) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6682505-6 | Bronchospasm, Dyspnoea, Flushing
on Apr 08, 2010 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with type 1 diabetes mellitus and was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: bronchospasm, dyspnoea, flushing. Actrapid dosage: 6 Iu, Qd. Patient was hospitalized.

6663357-7 | Stevens-johnson Syndrome
on Mar 24, 2010 Female patient from FRANCE , 47 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Actrapid dosage: Uk/sc. During the same period patient was treated with HUMALOG (Unk) (View Humalog Review and Humalog Label ), PROPOFOL (View Propofol Review and Propofol Label ), AUGMENTIN '125' (6 G, Qd) (View Augmentin '125' Review and Augmentin '125' Label ), MOPRAL /00661201/ (40 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), CANCIDAS (50 Mg, Qd) (View Cancidas Review and Cancidas Label ), SUFENTANIL CITRATE (Unk) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ACUPAN (Unk) (View Acupan Review and Acupan Label ), METFORMIN (GLUCOPHAGE) (300 Mg, Qd) (View Metformin (glucophage) Review and Metformin (glucophage) Label ). Patient was hospitalized.

6615220-5 |
Patient was taking Actrapid (View Usage). on Feb 25, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with type 1 diabetes mellitus and. Actrapid dosage: Uk/sc. During the same period patient was treated with LEVEMIR (Uk/sc) (View Levemir Review and Levemir Label ), LERCAN (10 Mg, Qd) (View Lercan Review and Lercan Label ), VASTAREL (35 Mg, Qd) (View Vastarel Review and Vastarel Label ), TRIVASTAL /00397201/ (50 Mg, Qd) (View Trivastal /00397201/ Review and Trivastal /00397201/ Label ), MODOPAR (View Modopar Review and Modopar Label ), CAPTOPRIL AND HYDROCHLOROTHIAZIDE (View Captopril And Hydrochlorothiazide Review and Captopril And Hydrochlorothiazide Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6615211-4 | Fall, Head Injury, Hypoglycaemia
Adverse event was reported on Feb 23, 2010 by a Female patient taking Actrapid (View Usage) (Dosage: 60 Iu, Qd) was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), hypertension, myocardial ischaemia, hyperuricaemia and. Location: ITALY , 83 years of age, After Actrapid was administered, patient had the following side effects: fall (What is fall?), head injury, hypoglycaemia. During the same period patient was treated with CARVEDILOL (12.5 Mg, Qd) (View Carvedilol Review and Carvedilol Label ), APROVEL (300 Mg, Qd) (View Aprovel Review and Aprovel Label ), MINITRAN /00003201/ (5 Mg, Qd) (View Minitran /00003201/ Review and Minitran /00003201/ Label ), LASITONE (25+37 Mg) (View Lasitone Review and Lasitone Label ), LASIX (25 Mg, Qd) (View Lasix Review and Lasix Label ), ZYLORIC /00003301/ (150 Mg, Qd) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ). Patient was hospitalized.

6577085-X | Syncope
on Feb 02, 2010 Male patient from GERMANY , 64 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Actrapid dosage: 34 Iu, Qd. During the same period patient was treated with LANTUS (20 U, Qd) (View Lantus Review and Lantus Label ), TAMSULIN (.4 Mg, Qd) (View Tamsulin Review and Tamsulin Label ), BELOC ZOK (Unk) (View Beloc Zok Review and Beloc Zok Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), TORSEMIDE (Unk) (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6564699-6 |
on Jan 26, 2010 Female patient from FRANCE , 81 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Actrapid (View Usage). . Actrapid dosage: Uk/sc. During the same period patient was treated with LEVEMIR (Uk/sc) (View Levemir Review and Levemir Label ), LERCAN (10 Mg, Qd) (View Lercan Review and Lercan Label ), VASTAREL (35 Mg, Qd) (View Vastarel Review and Vastarel Label ), TRIVASTAL /00397201/ (50 Mg, Qd) (View Trivastal /00397201/ Review and Trivastal /00397201/ Label ), MODOPAR (View Modopar Review and Modopar Label ), CAPTOPRIL AND HYDROCHLOROTHIAZIDE (View Captopril And Hydrochlorothiazide Review and Captopril And Hydrochlorothiazide Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

6505408-6 | Hyperthermia, Infusion Site Phlebitis
Patient was taking Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: hyperthermia, infusion site phlebitis on Dec 11, 2009 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with type 2 diabetes mellitus and. Actrapid dosage: Uk/iv. During the same period patient was treated with COAPROVEL (Unk) (View Coaprovel Review and Coaprovel Label ), LOXEN (6 Pharmaceutical Doses Pr Hour) (View Loxen Review and Loxen Label ), PREVISCAN /00261401/ (20 Mg, Unk) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), NORSET (View Norset Review and Norset Label ), IMOVANE (7.5 Mg, Unk) (View Imovane Review and Imovane Label ), LEVOTHYROXINE SODIUM (125 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MOPRAL /00661201/ (20 Mg, Unk) (View Mopral /00661201/ Review and Mopral /00661201/ Label ). Patient was hospitalized.

6444476-7 | Myocardial Infarction
Adverse event was reported on Nov 09, 2009 by a Female patient taking Actrapid (View Usage) (Dosage: ) . Location: NETHERLANDS , 86 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with INOTROPIN (View Inotropin Review and Inotropin Label ). Patient was hospitalized.

6421574-5 | Myocardial Infarction
on Oct 22, 2009 Female patient from NETHERLANDS , 86 years of age, was treated with Actrapid (View Usage). Patient had the following side effects: myocardial infarction. Actrapid dosage: . During the same period patient was treated with INOTROPIN (View Inotropin Review and Inotropin Label ). Patient was hospitalized.

6419218-1 | Blood Glucose Increased, Cardiogenic Shock
on Oct 22, 2009 Male patient from NETHERLANDS , 78 years of age, was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: blood glucose increased, cardiogenic shock. Actrapid dosage: Less Than 10 Iu Per Hour. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ENOXIMONE (View Enoximone Review and Enoximone Label ), NORADRENALIN /00127501/ (View Noradrenalin /00127501/ Review and Noradrenalin /00127501/ Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), CORDARONE (View Cordarone Review and Cordarone Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6403534-3 | Cardiogenic Shock
Patient was taking Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock on Oct 06, 2009 from NETHERLANDS Additional patient health information: Male patient , 78 years of age, . Actrapid dosage: }10 Iu/hour. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ENOXIMONE (View Enoximone Review and Enoximone Label ), NORADRENALIN /00127501/ (View Noradrenalin /00127501/ Review and Noradrenalin /00127501/ Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), CORDARONE (View Cordarone Review and Cordarone Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6402107-6 | Myocardial Infarction
Adverse event was reported on Oct 06, 2009 by a Female patient taking Actrapid (View Usage) (Dosage: ) . Location: NETHERLANDS , 86 years of age, Patient had the following side effects: myocardial infarction. During the same period patient was treated with INOTROPIN (View Inotropin Review and Inotropin Label ). Patient was hospitalized.

6393162-0 | Blood Glucose Increased, Insulin Resistance Syndrome
on Oct 01, 2009 Male patient from AUSTRALIA , 69 years of age, weighting 222.7 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: blood glucose increased, insulin resistance syndrome. Actrapid dosage: 60 U, Tid. During the same period patient was treated with NOVORAPID (Before Meals) (View Novorapid Review and Novorapid Label ), LANTUS (50 U, Bid) (View Lantus Review and Lantus Label ), ATACAND (8 Mg, Qd) (View Atacand Review and Atacand Label ), CARDIZEM (240 Mg, Bid) (View Cardizem Review and Cardizem Label ), FRUSEMIDE /00032601/ (40 Mg, Qd) (View Frusemide /00032601/ Review and Frusemide /00032601/ Label ), PROPRANOLOL (20 Mg, Tid) (View Propranolol Review and Propranolol Label ), PRAVACHOL (20 Mg, Qd) (View Pravachol Review and Pravachol Label ), LIPIDIL (145 Mg, Qd) (View Lipidil Review and Lipidil Label ). Patient was hospitalized.

6337764-6 | Bronchospasm, Dyspnoea, Flushing
on Aug 24, 2009 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with type 1 diabetes mellitus and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, dyspnoea, flushing. Actrapid dosage: 6 Iu, Qd.

6288292-8 | Blood Glucose Increased, Insulin Resistance Syndrome
Patient was taking Actrapid (View Usage). Patient had the following side effects: blood glucose increased, insulin resistance syndrome on Jul 20, 2009 from AUSTRALIA Additional patient health information: Male patient , 69 years of age, weighting 222.7 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Actrapid dosage: 60 U, Tid. During the same period patient was treated with NOVORAPID (Before Meals) (View Novorapid Review and Novorapid Label ), LANTUS (50 U, Bid) (View Lantus Review and Lantus Label ), ATACAND (8 Mg, Qd) (View Atacand Review and Atacand Label ), CARDIZEM (240 Mg, Bid) (View Cardizem Review and Cardizem Label ), FRUSEMIDE /00032601/ (40 Mg, Qd) (View Frusemide /00032601/ Review and Frusemide /00032601/ Label ), PROPRANOLOL (20 Mg, Tid) (View Propranolol Review and Propranolol Label ), PRAVACHOL (20 Mg, Qd) (View Pravachol Review and Pravachol Label ), LIPIDIL (145 Mg, Qd) (View Lipidil Review and Lipidil Label ). Patient was hospitalized.

6216175-8 | Hypoglycaemia
Adverse event was reported on May 28, 2009 by a Male patient taking Actrapid (View Usage) (Dosage: 20 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: FRANCE , 84 years of age, weighting 141.1 lb, After Actrapid was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MOPRAL /00661201/ (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PERMIXON /00833501/ (View Permixon /00833501/ Review and Permixon /00833501/ Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), MOVICOL /01053601/ (View Movicol /01053601/ Review and Movicol /01053601/ Label ). Patient was hospitalized.

6215222-7 | Anorexia, Cardiac Failure, Cholestasis, Overdose, Renal Failure
on May 26, 2009 Female patient from FRANCE , 82 years of age, was diagnosed with type 2 diabetes mellitus, cardiac failure, hypertension and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, cardiac failure, cholestasis, overdose, renal failure. Actrapid dosage: 12 Iu, 2+5+5. During the same period patient was treated with DIGITALINE NATIVELLE (.25 Mg, Qd) (View Digitaline Nativelle Review and Digitaline Nativelle Label ), ALDACTONE (25 Mg, Qd) (View Aldactone Review and Aldactone Label ), TRIATEC /00885601/ (10 Mg, Qd) (View Triatec /00885601/ Review and Triatec /00885601/ Label ), AMLOR (View Amlor Review and Amlor Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), PRAXILENE (View Praxilene Review and Praxilene Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

6184497-5 | Hypoglycaemia, Malaise
on Apr 28, 2009 Male patient from FRANCE , 84 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Actrapid (View Usage). Patient had the following side effects: hypoglycaemia, malaise. Actrapid dosage: 20 Iu, Qd. During the same period patient was treated with LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), MOPRAL /00661201/ (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PERMIXON /00833501/ (View Permixon /00833501/ Review and Permixon /00833501/ Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), MOVICOL /01053601/ (View Movicol /01053601/ Review and Movicol /01053601/ Label ). Patient was hospitalized.

6048769-7 | Syncope
Patient was taking Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: syncope on Jan 13, 2009 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Actrapid dosage: 34 Iu, Qd. During the same period patient was treated with LANTUS (20 U, Qd) (View Lantus Review and Lantus Label ), TAMSULIN (.4 Mg, Qd) (View Tamsulin Review and Tamsulin Label ). Patient was hospitalized.

6033906-0 | Angioedema, Rash Maculo-papular
Adverse event was reported on Jan 07, 2009 by a Male patient taking Actrapid (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: SWITZERLAND , 46 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: angioedema, rash maculo-papular. During the same period patient was treated with ENALAPRIL MALEATE (5 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOLO (50 Mg, Qd) (View Metoprololo Review and Metoprololo Label ), HEPARIN (View Heparin Review and Heparin Label ), RANITIDINE (150 Mg, Qd) (View Ranitidine Review and Ranitidine Label ), BROMAZEPAN (2 X 1.5 Mg) (View Bromazepan Review and Bromazepan Label ), ATORVASTATIN CALCIUM (40 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LEVOCETIRIZINE (5 Mg/d) (View Levocetirizine Review and Levocetirizine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6024711-X | Angioedema, Rash Maculo-papular
on Dec 23, 2008 Male patient from SWITZERLAND , 46 years of age, weighting 174.2 lb, was diagnosed with type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient had the following side effects: angioedema, rash maculo-papular. Actrapid dosage: . During the same period patient was treated with ENALAPRIL MALEATE (5 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOLO (50 Mg, Qd) (View Metoprololo Review and Metoprololo Label ), HEPARIN (View Heparin Review and Heparin Label ), RANITIDINE (150 Mg, Qd) (View Ranitidine Review and Ranitidine Label ), BROMAZEPAN (2 X 1.5 Mg) (View Bromazepan Review and Bromazepan Label ), ATORVASTATIN CALCIUM (40 Mg, Qd) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LEVOCETIRIZINE (5 Mg/d) (View Levocetirizine Review and Levocetirizine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6015267-6 | Confusional State, Hyperglycaemia, Hypoglycaemia, Hypoglycaemic Coma, Hypothermia, Psychomotor Retardation
on Dec 15, 2008 Female patient from FRANCE , 71 years of age, weighting 130.1 lb, was diagnosed with hyperglycaemia, immunodeficiency and was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: confusional state, hyperglycaemia, hypoglycaemia, hypoglycaemic coma, hypothermia (What is hypothermia?), psychomotor retardation. Actrapid dosage: . During the same period patient was treated with IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ). Patient was hospitalized.

6008471-4 | Cardio-respiratory Arrest, Renal Failure Acute
Patient was taking Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, renal failure acute on Feb 29, 2008 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Actrapid dosage: Unk, Unk. During the same period patient was treated with AMBISOME (10 Mg/kg, Qd) (View Ambisome Review and Ambisome Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), LANTUS (View Lantus Review and Lantus Label ).

5993742-8 | Confusional State, Hyperglycaemia, Hypoglycaemia, Hypoglycaemic Coma, Hypothermia, Psychomotor Retardation
Adverse event was reported on Dec 01, 2008 by a Female patient taking Actrapid (View Usage) (Dosage: ) . Location: FRANCE , 71 years of age, Patient had the following side effects: confusional state, hyperglycaemia, hypoglycaemia, hypoglycaemic coma, hypothermia (What is hypothermia?), psychomotor retardation. Patient was hospitalized.

5967898-7 | Coma, Confusional State, Hyperglycaemia, Hypoglycaemia, Hypothermia, Psychomotor Retardation
on Nov 18, 2008 Female patient from FRANCE , 71 years of age, was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: coma, confusional state, hyperglycaemia, hypoglycaemia, hypothermia (What is hypothermia?), psychomotor retardation. Actrapid dosage: . Patient was hospitalized.

5902913-8 | Cerebral Ischaemia, Depressed Level Of Consciousness, Hypoglycaemia, Respiratory Failure
on Sep 19, 2008 Male patient from FRANCE , 73 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, depressed level of consciousness, hypoglycaemia, respiratory failure. Actrapid dosage: . During the same period patient was treated with MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), CARDENSIEL (1.25 Mg, Qd) (View Cardensiel Review and Cardensiel Label ), ZYLORIC /00003301/ (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), MOPRAL /00661201/ (20 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PREVISCAN /00261401/ (20 Mg, Qd) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LASIX (500 Mg, Qd) (View Lasix Review and Lasix Label ), OROCAL /00108001/ (500 Mg, Qd) (View Orocal /00108001/ Review and Orocal /00108001/ Label ). Patient was hospitalized.

5871708-6 | Caesarean Section, Premature Labour, Pseudomembranous Colitis
Patient was taking Actrapid (View Usage). Patient had the following side effects: caesarean section, premature labour, pseudomembranous colitis on Aug 28, 2008 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with colitis and. Actrapid dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), MOPRAL /00661201/ (View Mopral /00661201/ Review and Mopral /00661201/ Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), FLAGYL (View Flagyl Review and Flagyl Label ), ATARAX (View Atarax Review and Atarax Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.

5868605-9 | Atrial Septal Defect, Congenital Diaphragmatic Hernia
Adverse event was reported on Aug 22, 2008 by a Female patient taking Actrapid (View Usage) (Dosage: ) . Location: FRANCE , weighting 4.43 lb, After Actrapid was administered, patient had the following side effects: atrial septal defect, congenital diaphragmatic hernia. During the same period patient was treated with INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ).

5859862-3 | Cerebral Ischaemia, Depressed Level Of Consciousness, Hypoglycaemia, Respiratory Failure
on Aug 18, 2008 Male patient from FRANCE , 73 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, depressed level of consciousness, hypoglycaemia, respiratory failure. Actrapid dosage: . During the same period patient was treated with MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), BISOPROLOL FUMARATE (1.25 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ZYLORIC /00003301/ (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), MOPRAL /00661201/ (20 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PREVISCAN /00261401/ (20 Mg, Qd) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LASIX (500 Mg, Qd) (View Lasix Review and Lasix Label ), OROCAL /00108001/ (500 Mg, Qd) (View Orocal /00108001/ Review and Orocal /00108001/ Label ). Patient was hospitalized.

5855975-0 | Anaemia, Thrombocytopenia
on Aug 12, 2008 Male patient from FRANCE , 68 years of age, was treated with Actrapid (View Usage). Patient had the following side effects: anaemia, thrombocytopenia. Actrapid dosage: Unk, Unk. During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), VITAMIN B1 1MGM TAB (View Vitamin B1 1mgm Tab Review and Vitamin B1 1mgm Tab Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), CLAFORAN (4 G, Qd) (View Claforan Review and Claforan Label ), NICOBION (View Nicobion Review and Nicobion Label ), HUMAN ALBUMIN /01102501/ (View Human Albumin /01102501/ Review and Human Albumin /01102501/ Label ). Patient was hospitalized.

5802754-6 | Injection Site Abscess
Patient was taking Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: injection site abscess on Jun 27, 2008 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with type 2 diabetes mellitus and. Actrapid dosage: . Patient was hospitalized.

5801580-1 | Burning Sensation, Heart Rate Irregular, Irritability, Neuropathy Peripheral, Pain In Extremity, Sleep Disorder
Adverse event was reported on Jun 24, 2008 by a Male patient taking Actrapid (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED KINGDOM , 61 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, heart rate irregular, irritability, neuropathy peripheral, pain in extremity, sleep disorder (What is sleep disorder?).

5795865-5 | Cerebral Ischaemia, Coma, Depressed Level Of Consciousness, Head Injury, Hypoglycaemia, Hypotension, Respiratory Failure
on Jun 17, 2008 Male patient from FRANCE , 73 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Actrapid (View Usage). Patient had the following side effects: cerebral ischaemia, coma, depressed level of consciousness, head injury, hypoglycaemia, hypotension, respiratory failure. Actrapid dosage: . During the same period patient was treated with MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), BISOPROLOL FUMARATE (1.25 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ZYLORIC /00003301/ (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), MOPRAL /00661201/ (20 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PREVISCAN /00261401/ (20 Mg, Qd) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LASIX (500 Mg, Qd) (View Lasix Review and Lasix Label ), OROCAL /00108001/ (500 Mg, Qd) (View Orocal /00108001/ Review and Orocal /00108001/ Label ). Patient was hospitalized.

5766675-X | Caesarean Section, Premature Labour, Pseudomembranous Colitis
on May 29, 2008 Female patient from FRANCE , 34 years of age, was diagnosed with colitis and was treated with Actrapid (View Usage). After Actrapid was administered, patient had the following side effects: caesarean section, premature labour, pseudomembranous colitis. Actrapid dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), MOPRAL /00661201/ (View Mopral /00661201/ Review and Mopral /00661201/ Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), FLAGYL (View Flagyl Review and Flagyl Label ), ATARAX (View Atarax Review and Atarax Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ). Patient was hospitalized.

5760813-0 | Injection Site Abscess
Patient was taking Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: injection site abscess on May 27, 2008 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with diabetes mellitus and. Actrapid dosage: . Patient was hospitalized.

5752354-1 | Depressed Level Of Consciousness, Hypoglycaemia
Adverse event was reported on May 19, 2008 by a Male patient taking Actrapid (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: FRANCE , 73 years of age, Patient had the following side effects: depressed level of consciousness, hypoglycaemia. During the same period patient was treated with MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), CARDENSIEL (1.25 Mg, Qd) (View Cardensiel Review and Cardensiel Label ), ZYLORIC /00003301/ (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), MOPRAL /00661201/ (20 Mg, Qd) (View Mopral /00661201/ Review and Mopral /00661201/ Label ), PREVISCAN /00261401/ (20 Mg, Qd) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), LASILIX /00032601/ (500 Mg, Qd) (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), OROCAL /00108001/ (500 Mg, Qd) (View Orocal /00108001/ Review and Orocal /00108001/ Label ). Patient was hospitalized.

5701906-3 |
on Apr 01, 2008 Male patient from UNITED STATES , weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Actrapid (View Usage). . Actrapid dosage: 14 Iu, Tid. During the same period patient was treated with PROTAPHANE (18 Iu, Qd) (View Protaphane Review and Protaphane Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

5695491-2 | Caesarean Section, Emergency Care
on Oct 15, 2007 Female patient from ROMANIA , weighting 242.5 lb, was treated with Actrapid (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, emergency care. Actrapid dosage: 50 U, Qd. During the same period patient was treated with INSULATARD (24 U, Qd) (View Insulatard Review and Insulatard Label ). Patient was hospitalized.

5688847-5 |
Patient was taking Actrapid (View Usage). on Mar 20, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus and. Actrapid dosage: 14 Iu, Tid. During the same period patient was treated with PROTAPHANE (18 Iu, Qd) (View Protaphane Review and Protaphane Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).